Insulin Sensitivity and Insulin Resistance in Non-Diabetic Middle-Aged Patients with Obstructive Sleep Apnoea Syndrome

Table 3: Laboratory results and measurements of obstructive sleep apnoea syndrome (OSAS) patients.

-	OSAS patients *n=69*
FEV₁ (% predicted)	92 (72.4-97.6)
FVC (% predicted)	83.8 ± 20.7
FEV₁/FVC (%)	82 (79.4-85.1)
pO₂ (mmHg)	78.2 ± 10.5
pCO₂ (mmHg)	40 (38.5-45)
SBP (mmHg)	125 (120-130)
DBP (mmHg)	80 (75-80)
Glucose (mg/dL)	94 (84-120)
Creatinine (mg/dL)	0.9 ± 0.16
Cholesterol (mg/dL)	197 ± 39
Triglycerides (mg/dL)	159 (106-186)
LDL-C (mg/dL)	106 (95-129)
HDL-C (mg/dL)	46 ± 11
CRP (mg/dL)	0.46 (0.22-0.93)
SGOT (U/L)	22 (17-31)
SGPT (U/L)	32 (18-44)
Insulin (μU/mL)	15.6 (8.6-29)
HOMA-IR	3.55 (2.23-12.2)
QUICKI	0.31 ± 0.06

CRP: C-reactive protein, DBP: Diastolic blood pressure, FEV₁: Forced expiratory volume in 1^st sec, FVC: Forced vital capacity, HDL-C: High density lipoprotein-cholesterol, HOMA-IR: Homeostasis model assessment of insulin resistance, LDL-C: Low density lipoprotein-cholesterol, pCO₂: Carbon dioxide partial pressure, pO₂: Oxygen partial pressure, QUICKI: Quantitative insulin sensitivity check index, SBP: Systolic blood pressure.